Literature DB >> 18687751

Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice.

Kosuke Okada1, Junichi Shoda, Keiko Taguchi, Jonathan M Maher, Kaoru Ishizaki, Yoshimi Inoue, Makio Ohtsuki, Nobuharu Goto, Koichi Takeda, Hirotoshi Utsunomiya, Koji Oda, Eiji Warabi, Tetsuro Ishii, Keiko Osaka, Ichinosuke Hyodo, Masayuki Yamamoto.   

Abstract

The protective action of ursodeoxycholic acid (UDCA) in cholestatic liver diseases may be mediated by choleresis, detoxification, and cytoprotection against oxidative stress. Nrf2, one transcription factor, serves as a cellular stress sensor and is a key regulator for hepatic induction of detoxifying enzymes, antioxidative stress genes, and numerous Mrp family members. We aimed to investigate whether UDCA induces hepatic Mrp expression along with that of detoxifying enzymes and antioxidative stress genes via the Nrf2 transcriptional pathway. The protein level, subcellular localization, and mRNA level of Mrp family members were assessed in livers of Keap1 gene-knockdown (Keap1-kd) mice and those of UDCA-fed wild-type (WT) and Nrf2 gene-null (Nrf2-null) mice. Nuclear levels of Nrf2 in livers of Keap1-kd mice markedly increased, resulting in constitutive activation of Nrf2. Keap1-kd mice have high-level expression of hepatic Mrp2, Mrp3, and Mrp4 relative to WT mice. UDCA potently increased nuclear Nrf2 expression level in livers of WT mice, and the treatment showed maximal hepatic induction of Mrp2, Mrp3, and Mrp4 in association with enhanced membranous localizations in an Nrf2-dependent manner. UDCA similarly increased nuclear Nrf2 expression level in rat hepatocytes. Chromatin immunoprecipitation assays using mouse hepatocytes revealed the binding of Nrf2 to antioxidant response elements in the promoter regions of Mrp2, Mrp3, and Mrp4. These findings demonstrate an important role of Nrf2 in the induction of Mrp family members in livers and suggest that a therapeutic mechanism of UDCA action is, via Nrf2 activation, a stimulation of detoxification and antioxidative stress systems, along with Mrp-mediated efflux transport.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687751     DOI: 10.1152/ajpgi.90321.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  50 in total

1.  Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins.

Authors:  Hiromi Yamazaki; Fumiki Katsuoka; Hozumi Motohashi; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

Review 2.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

3.  Participation of nuclear factor (erythroid 2-related), factor 2 in ameliorating lithocholic acid-induced cholestatic liver injury in mice.

Authors:  K P Tan; G A Wood; M Yang; S Ito
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 4.  Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.

Authors:  Brandon Swift; Nathan D Pfeifer; Kim L R Brouwer
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

5.  Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway.

Authors:  Sukirti Kalra; Ying Zhang; Elena V Knatko; Stewart Finlayson; Masayuki Yamamoto; Albena T Dinkova-Kostova
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-29

6.  Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.

Authors:  Kosuke Okada; Eiji Warabi; Hirokazu Sugimoto; Masaki Horie; Katsutoshi Tokushige; Tetsuya Ueda; Nobuhiko Harada; Keiko Taguchi; Etsuko Hashimoto; Ken Itoh; Tetsuro Ishii; Hirotoshi Utsunomiya; Masayuki Yamamoto; Junichi Shoda
Journal:  J Gastroenterol       Date:  2012-02-28       Impact factor: 7.527

Review 7.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

8.  18β-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1/FXR signaling pathway.

Authors:  Shou-Yan Wu; Shi-Chao Cui; Le Wang; Yi-Ting Zhang; Xiao-Xia Yan; Heng-Lei Lu; Guo-Zhen Xing; Jin Ren; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2018-07-30       Impact factor: 6.150

9.  Effects of ablation and activation of Nrf2 on bile acid homeostasis in male mice.

Authors:  Youcai Zhang; Andrew J Lickteig; Jing Liu; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-29       Impact factor: 4.219

10.  The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.

Authors:  Suna Zhou; Wenguang Ye; Xiaoyi Duan; Mingxin Zhang; Jiansheng Wang
Journal:  Dig Dis Sci       Date:  2013-01-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.